Mustang Bio - 48 Year Dividend Yield History | MBIO

Historical dividend payout and yield for Mustang Bio (MBIO) since 1971. The current TTM dividend payout for Mustang Bio (MBIO) as of March 20, 2019 is $0.00. The current dividend yield for Mustang Bio as of March 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.108B $0.000B
Mustang Bio, Inc. a subsidiary of Fortress Biotech, Inc., is a clinical?stage biopharmaceutical company. It focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient's own immune system to eliminate cancer cells. Mustang Bio, Inc. is based in New York, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.160B 13.29
Gilead Sciences (GILD) United States $83.533B 10.63
Bio-Techne Corp (TECH) United States $7.518B 50.65